Expression of endothelial and inducible NOS-isoforms is increased in Alzheimer's disease, in APP23 transgenic mice and after experimental brain lesion in rat: Evidence for an induction by amyloid pathology

Brain Research

Volumn 913, Issue 1, 2001, Pages 57-67

  Lüth, Hans Joachim ^a   Holzer, Max ^a   Gärtner, Ulrich ^a   Staufenbiel, Matthias ^b   Arendt, Thomas ^a  

^a UNIVERSITY OF LEIPZIG   (Germany)

^b NOVARTIS PHARMA AG   (Switzerland)

Author keywords

Amyloid; Alzheimer's disease; APP; Astrocytosis; Nitric oxide synthase

Indexed keywords

AMYLOID PRECURSOR PROTEIN; ISOPROTEIN; NITRIC OXIDE; NITRIC OXIDE SYNTHASE;

AGED; ALZHEIMER DISEASE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASTROCYTOSIS; BRAIN INJURY; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM; ENZYME INDUCTION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; MOUSE; MUTATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RAT; TRANSGENIC MOUSE;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; ANTIBODY SPECIFICITY; ASTROCYTES; BRAIN; BRAIN INJURIES; CELL COUNT; CEREBRAL CORTEX; FEMALE; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GLIOSIS; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MICE; MICE, TRANSGENIC; NITRIC OXIDE SYNTHASE; PROMOTER REGIONS (GENETICS); PROTEIN ISOFORMS; SENILE PLAQUES; UP-REGULATION;

EID: 0035860603     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(01)02758-5     Document Type: Article

References (79)

1. β-Amyloid stimulation of inducible nitric oxide synthase in astrocytes is interleukin-1beta- and tumor necrosis factor-alpha (TNFalpha)-dependent, and involves a TNFalpha receptor-associated factor- and NFkappaB-inducing kinase dependent signaling mechanism
2. Cell mediators of inflammation in the Alzheimer disease brain
3. Increased expression and subcellular translocation of the mitogen-activated protein kinase kinase and mitogen-activated protein kinase in Alzheimer's disease
4. Activation of the inducible form of nitric oxide synthase in the brain of patients with multiple sclerosis
5. Activation of type III nitric oxide synthase in astrocytes following a neurotropic viral infection
6. Transient changes in the presence of nitric oxide synthases and nitrotyrosine immunoreactivity after focal cortical lesions
7. Transgenic mouse models of Alzheimer's disease
8. Endogenous nitric oxide synthesis: Biological functions and pathophysiology
9. Oxidative stress is associated with region-specific neuronal death during thiamine deficiency
10. Cytokine-stimulated astrocytes damage human neurons via a nitric oxide mechanism
11. Inducible nitric oxide synthase expression in cerebrovascular smooth muscle and neutrophils after traumatic brain injury in immature rats
12. Nitric oxide in neurodegeneration
13. Regulation of neuronal nitric oxide synthase and identification of novel nitric oxide signaling pathways
14. Endothelial nitric oxide synthase localized to hippocampal pyramidal cells: Implications for synaptic plasticity
15. Nitric oxide synthase activity is elevated in brain microvessels in Alzheimer's disease
16. Localization of neuronal and endothelial nitric oxide synthase isoforms in human hippocampus
17. Expression of the inducible form of nitric oxide synthase by reactive astrocytes after transient global ischemia
18. Antioxidants, oxidative stress, and degenerative neurological disorders
19. Isoforms of nitric oxide synthase. Properties, cellular distribution and expressional control
20. Nitric oxide synthase expression and expressional control of the three isoforms
21. Astroglia in Alzheimer's disease
22. Localisation of NADPH diaphorase activity and NOS immunoreactivity in astroglia in normal adult rat brain
23. Silver staining of Alzheimer's neurofibrillary changes by means of physical development
24. Induction of p21 ras in Alzheimer pathology
25. Elevated expression of p21 ras is an early event in Alzheimer's disease and precedes neurofibrillary degeneration
26. Evidence for neuronal oxidative damage in Alzheimer's disease
27. Hydrofluoric acid-treated tau PHF proteins display the same biochemical properties as normal tau
28. Regulation of expression of the endothelial cell nitric oxide synthase
29. Reactive oxygen species, cell signaling, and cell injury
30. Beta-Amyloid 25-35 activates nitric oxide synthase in a neuronal clone
31. Amyloid-beta peptide activates cultured astrocytes: Morphological alterations, cytokine induction and nitric oxide release
32. Nitric oxide synthase and neuronal vulnerability in Parkinson's disease
33. Inducible nitric oxide synthase gene expression in brain following cerebral ischemia
34. Induction of endothelial nitric oxide synthase in rat brain astrocytes by systemic lipopolysaccharide treatment
35. A central role for astrocytes in the inflammatory response to beta-amyloid; chemokines, cytokines and reactive oxygen species are produced
36. Nitric oxide synthase and neurodegeneration/neuroprotection
37. Diagnosis of Alzheimer's disease
38. Nitric oxide-stimulated guanine nucleotide exchange on p21 ras
39. Interleukin-1, nitric oxide and reactive astrocytes
40. Cytokine regulation of iNOS expression in human glial cells
41. Inducible nitric oxide synthase stimulates dopaminergic neurodegeneration in the MPTP model of Parkinson disease
42. Morphological analyses of NADPH-diaphorase/nitric oxide synthase positive structures in human visual cortex
43. Co-expression of APP with cNOS but not iNOS after cortical injury in rat
44. Ultrastuctural demonstration of constitutive nitric oxide synthase (cNOS) in neocortical glial cells and glial perisynaptic sheaths
45. Nitric oxide and Alzheimer's disease
46. Aberrant expression of nNOS in pyramidal neurons in Alzheimer's disease is highly co-localized with p21 ras and p16INK4a
47. Clinical diagnosis of Alzheimer's disease: Report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease
48. Nitric oxide as a potential pathological mechanism in demyelination: Its differential effects on primary glial cells in vitro
49. Release of nitric oxide from astroglial cells: A key mechanism in neuroimmune disorders
50. Nitric oxide: Discovery and impact on clinical medicine
51. Brain glutamate decorboxylase in Parkinson's disease with particular reference to premortem severity index
52. Aberrant expression of the constitutive endothelial nitric oxide synthase gene in Alzheimer disease
53. Aberrant expression of nitric oxide synthase III in Alzheimer's disease: Relevance to cerebral vasculopathy and neurodegeneration
54. A quantitative study of neurofibrillary tangles, senile plaques and astrocytes in the hippocampal subdivisions and entorhinal cortex in Alzheimer's disease, normal and non-Alzheimer neuropsychiatric diseases
55. Production of nitric oxide by glial cells: Regulation and potential roles in the CNS
56. Neuronal nitric oxide synthase (nNOS) mRNA expression and NADPH-diaphorase staining in the frontal cortex, visual cortex and hippocampus of control and Alzheimer's disease brains
57. Duration of expression of inducible nitric oxide synthase in glial cells
58. Expression of inducible nitric oxide synthase in distinct cellular types after traumatic brain injury: An in situ hybridization and immunocytochemical study
59. β-Amyloid-induced changes in cultured astrocytes parallel reactive astrocytosis associated with senile plaques in Alzheimer's disease
60. Early association of reactive astrocytes with senile plaques in Alzheimer's disease
61. Senile dementia of Alzheimer type: Astroglial reaction to extracellular neurofibrillary tangles in the hippocampus. An immunohistochemical and electron-microscopic study
62. Bilateral induction of NADPH diaphorase activity in neocortical and hippocampal neurons by unilateral injury
63. Synergistic induction of nitric oxide by β-amyloid and cytokines in astrocytes
64. Role of nitric oxide in neurodegenerative diseases
65. Involvement of nitric oxide in acute spinal cord injury: An immunohistochemical study using light and electron microscopy in the rat
66. Neuritic sprouting with aberrant expression of the nitric oxide synthase III gene in neurodegenerative disease
67. Transgenic approaches to model Alzheimer's disease
68. Two amyloid precursor protein transgenic mouse models with Alzheimer disease-like pathology
69. nNOS expressing neurons in the entorhinal cortex and hippocampus are affected in patients with Alzheimer's disease
70. Production, regulation and role of nitric oxide in glial cells
71. Inducible nitric oxide synthase in tangle-bearing neurons of patients with Alzheimer's disease
72. NADPH-diaphorase activity in activated astrocytes represents inducible nitric oxide synthase
73. Nitric oxide synthase in reactive astrocytes adjacent to β-amyloid plaques
74. Endothelial nitric oxide synthase (eNOS) in astrocytes: Another source of nitric oxide in neocortex
75. Endothelial nitric oxide synthase and LTP
76. Neuronal nitric oxide synthase is induced in spinal neurons by traumatic injury
77. Nitric oxide synthase neurons in different areas of normal aged and Alzheimer's brains
78. Nitric oxide mediates N-methyl-D-aspartate receptor-induced activation of p21 ras